Skip to search formSkip to main contentSkip to account menu

Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547

Known as: 1C1-mcMMAF 
An auristatin analogue immunoconjugate directed against Eph receptor A2 (EphA2)-positive cancer cells with potential antineoplastic activity. Anti… 
National Institutes of Health

Search for papers about Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547

Search papers